 "Shasun board to consider conversion of warrants issued to Sequent Scientific")
The Board meeting will be held on June 8, 2015, for conversion of the warrants. The company is in the process of amalgamating itself with Strides Arcolab Ltd.
During the quarter ended June 30, 2014, the company has preferential allotment of 35,00,000 equity shares of Rs 2 each at a premium of Rs 108 per share aggregating to Rs 38.5 crore and 71,00,000 convertible warrants of Rs 2 each at a premium of Rs 108 per warrant to Sequent Scientific Ltd, Mumbai. The company has received Rs 19.53 crore, which is 25 per cent upfront issue price, towards allotment of the convertible warrants during the year.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app